世界の硬化療法市場予測 2020年-2025年

【英語タイトル】Global Sclerotherapy Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP3293)・商品コード:LPI20AP3293
・発行会社(調査会社):LP Information
・発行日:2020年3月30日(※2024年版があります。お問い合わせください)
・ページ数:164
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「硬化療法の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、洗剤、浸透圧剤、化学刺激剤など、用途別には、静脈疾患、消化管出血、気管支瘻、嚢胞性疾患などに区分してまとめた調査レポートです。硬化療法のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・硬化療法の世界市場概要(サマリー)
・硬化療法の企業別販売量・売上
・硬化療法の企業別市場シェア
・硬化療法の世界市場規模 2015年-2020年:種類別(洗剤、浸透圧剤、化学刺激剤)
・硬化療法の世界市場規模 2015年-2020年:用途別(静脈疾患、消化管出血、気管支瘻、嚢胞性疾患)
・硬化療法の米州市場規模(アメリカ、カナダ、メキシコなど)
・硬化療法のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・硬化療法の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・硬化療法の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・硬化療法市場の成長要因・課題・動向
・硬化療法の世界市場予測 2021年-2025年
・硬化療法の米州市場予測(アメリカ、カナダ、メキシコなど)
・硬化療法のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・硬化療法の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・硬化療法の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・硬化療法の世界市場予測:種類別(洗剤、浸透圧剤、化学刺激剤)
・硬化療法の世界市場予測:用途別(静脈疾患、消化管出血、気管支瘻、嚢胞性疾患)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Sclerotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sclerotherapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Sclerotherapy market by type, application, key manufacturers and key regions and countries.

This study considers the Sclerotherapy value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Detergents
Osmotic agents
Chemical irritants

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Venous disease
Gastrointestinal bleeding
Bronchopleural fistula
Cystic disease

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BTG
MTW ENDOSKOPIE
Kreussler
Troikaa
Changan Tianyu group
LGM Pharma
Angiodynamics
Bioniche Pharma Group Ltd
ENDO-FLEX
Omega Pharmaceuticals
Cook Medical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Sclerotherapy consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Sclerotherapy market by identifying its various subsegments.
Focuses on the key global Sclerotherapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sclerotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Sclerotherapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sclerotherapy Consumption 2015-2025
2.1.2 Sclerotherapy Consumption CAGR by Region
2.2 Sclerotherapy Segment by Type
2.2.1 Detergents
2.2.2 Osmotic agents
2.2.3 Chemical irritants
2.3 Sclerotherapy Consumption by Type
2.3.1 Global Sclerotherapy Consumption Market Share by Type (2015-2020)
2.3.2 Global Sclerotherapy Revenue and Market Share by Type (2015-2020)
2.3.3 Global Sclerotherapy Sale Price by Type (2015-2020)
2.4 Sclerotherapy Segment by Application
2.4.1 Venous disease
2.4.2 Gastrointestinal bleeding
2.4.3 Bronchopleural fistula
2.4.4 Cystic disease
2.5 Sclerotherapy Consumption by Application
2.5.1 Global Sclerotherapy Consumption Market Share by Type (2015-2020)
2.5.2 Global Sclerotherapy Value and Market Share by Type (2015-2020)
2.5.3 Global Sclerotherapy Sale Price by Type (2015-2020)

3 Global Sclerotherapy by Company
3.1 Global Sclerotherapy Sales Market Share by Company
3.1.1 Global Sclerotherapy Sales by Company (2018-2020)
3.1.2 Global Sclerotherapy Sales Market Share by Company (2018-2020)
3.2 Global Sclerotherapy Revenue Market Share by Company
3.2.1 Global Sclerotherapy Revenue by Company (2018-2020)
3.2.2 Global Sclerotherapy Revenue Market Share by Company (2018-2020)
3.3 Global Sclerotherapy Sale Price by Company
3.4 Global Sclerotherapy Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Sclerotherapy Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Sclerotherapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Sclerotherapy by Regions
4.1 Sclerotherapy by Regions
4.2 Americas Sclerotherapy Consumption Growth
4.3 APAC Sclerotherapy Consumption Growth
4.4 Europe Sclerotherapy Consumption Growth
4.5 Middle East & Africa Sclerotherapy Consumption Growth

5 Americas
5.1 Americas Sclerotherapy Consumption by Countries
5.1.1 Americas Sclerotherapy Consumption by Countries (2015-2020)
5.1.2 Americas Sclerotherapy Value by Countries (2015-2020)
5.2 Americas Sclerotherapy Consumption by Type
5.3 Americas Sclerotherapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Sclerotherapy Consumption by Regions
6.1.1 APAC Sclerotherapy Consumption by Regions (2015-2020)
6.1.2 APAC Sclerotherapy Value by Regions (2015-2020)
6.2 APAC Sclerotherapy Consumption by Type
6.3 APAC Sclerotherapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Sclerotherapy by Countries
7.1.1 Europe Sclerotherapy Consumption by Countries (2015-2020)
7.1.2 Europe Sclerotherapy Value by Countries (2015-2020)
7.2 Europe Sclerotherapy Consumption by Type
7.3 Europe Sclerotherapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Sclerotherapy by Countries
8.1.1 Middle East & Africa Sclerotherapy Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Sclerotherapy Value by Countries (2015-2020)
8.2 Middle East & Africa Sclerotherapy Consumption by Type
8.3 Middle East & Africa Sclerotherapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sclerotherapy Distributors
10.3 Sclerotherapy Customer

11 Global Sclerotherapy Market Forecast
11.1 Global Sclerotherapy Consumption Forecast (2021-2025)
11.2 Global Sclerotherapy Forecast by Regions
11.2.1 Global Sclerotherapy Forecast by Regions (2021-2025)
11.2.2 Global Sclerotherapy Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sclerotherapy Forecast by Type
11.8 Global Sclerotherapy Forecast by Application

12 Key Players Analysis
12.1 BTG
12.1.1 Company Information
12.1.2 Sclerotherapy Product Offered
12.1.3 BTG Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 BTG Latest Developments
12.2 MTW ENDOSKOPIE
12.2.1 Company Information
12.2.2 Sclerotherapy Product Offered
12.2.3 MTW ENDOSKOPIE Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 MTW ENDOSKOPIE Latest Developments
12.3 Kreussler
12.3.1 Company Information
12.3.2 Sclerotherapy Product Offered
12.3.3 Kreussler Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Kreussler Latest Developments
12.4 Troikaa
12.4.1 Company Information
12.4.2 Sclerotherapy Product Offered
12.4.3 Troikaa Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Troikaa Latest Developments
12.5 Changan Tianyu group
12.5.1 Company Information
12.5.2 Sclerotherapy Product Offered
12.5.3 Changan Tianyu group Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Changan Tianyu group Latest Developments
12.6 LGM Pharma
12.6.1 Company Information
12.6.2 Sclerotherapy Product Offered
12.6.3 LGM Pharma Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 LGM Pharma Latest Developments
12.7 Angiodynamics
12.7.1 Company Information
12.7.2 Sclerotherapy Product Offered
12.7.3 Angiodynamics Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Angiodynamics Latest Developments
12.8 Bioniche Pharma Group Ltd
12.8.1 Company Information
12.8.2 Sclerotherapy Product Offered
12.8.3 Bioniche Pharma Group Ltd Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Bioniche Pharma Group Ltd Latest Developments
12.9 ENDO-FLEX
12.9.1 Company Information
12.9.2 Sclerotherapy Product Offered
12.9.3 ENDO-FLEX Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 ENDO-FLEX Latest Developments
12.10 Omega Pharmaceuticals
12.10.1 Company Information
12.10.2 Sclerotherapy Product Offered
12.10.3 Omega Pharmaceuticals Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Omega Pharmaceuticals Latest Developments
12.11 Cook Medical
12.11.1 Company Information
12.11.2 Sclerotherapy Product Offered
12.11.3 Cook Medical Sclerotherapy Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Cook Medical Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Sclerotherapy Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Detergents
Table 5. Major Players of Osmotic agents
Table 6. Major Players of Chemical irritants
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Sclerotherapy Consumption Market Share by Type (2015-2020)
Table 9. Global Sclerotherapy Revenue by Type (2015-2020) ($ million)
Table 10. Global Sclerotherapy Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Sclerotherapy Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Sclerotherapy Consumption Market Share by Application (2015-2020)
Table 14. Global Sclerotherapy Value by Application (2015-2020)
Table 15. Global Sclerotherapy Value Market Share by Application (2015-2020)
Table 16. Global Sclerotherapy Sale Price by Application (2015-2020)
Table 17. Global Sclerotherapy Sales by Company (2017-2019) (K Pcs)
Table 18. Global Sclerotherapy Sales Market Share by Company (2017-2019)
Table 19. Global Sclerotherapy Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Sclerotherapy Revenue Market Share by Company (2017-2019)
Table 21. Global Sclerotherapy Sale Price by Company (2017-2019)
Table 22. Global Sclerotherapy Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Sclerotherapy Products Offered
Table 24. Sclerotherapy Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Sclerotherapy Consumption by Regions 2015-2020 (K Pcs)
Table 26. Global Sclerotherapy Consumption Market Share by Regions 2015-2020
Table 27. Global Sclerotherapy Value by Regions 2015-2020 ($ Millions)
Table 28. Global Sclerotherapy Value Market Share by Regions 2015-2020
Table 29. Americas Sclerotherapy Consumption by Countries (2015-2020) (K Pcs)
Table 30. Americas Sclerotherapy Consumption Market Share by Countries (2015-2020)
Table 31. Americas Sclerotherapy Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Sclerotherapy Value Market Share by Countries (2015-2020)
Table 33. Americas Sclerotherapy Consumption by Type (2015-2020) (K Pcs)
Table 34. Americas Sclerotherapy Consumption Market Share by Type (2015-2020)
Table 35. Americas Sclerotherapy Consumption by Application (2015-2020) (K Pcs)
Table 36. Americas Sclerotherapy Consumption Market Share by Application (2015-2020)
Table 37. APAC Sclerotherapy Consumption by Countries (2015-2020) (K Pcs)
Table 38. APAC Sclerotherapy Consumption Market Share by Countries (2015-2020)
Table 39. APAC Sclerotherapy Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Sclerotherapy Value Market Share by Regions (2015-2020)
Table 41. APAC Sclerotherapy Consumption by Type (2015-2020) (K Pcs)
Table 42. APAC Sclerotherapy Consumption Market Share by Type (2015-2020)
Table 43. APAC Sclerotherapy Consumption by Application (2015-2020) (K Pcs)
Table 44. APAC Sclerotherapy Consumption Market Share by Application (2015-2020)
Table 45. Europe Sclerotherapy Consumption by Countries (2015-2020) (K Pcs)
Table 46. Europe Sclerotherapy Consumption Market Share by Countries (2015-2020)
Table 47. Europe Sclerotherapy Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Sclerotherapy Value Market Share by Countries (2015-2020)
Table 49. Europe Sclerotherapy Consumption by Type (2015-2020) (K Pcs)
Table 50. Europe Sclerotherapy Consumption Market Share by Type (2015-2020)
Table 51. Europe Sclerotherapy Consumption by Application (2015-2020) (K Pcs)
Table 52. Europe Sclerotherapy Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Sclerotherapy Consumption by Countries (2015-2020) (K Pcs)
Table 54. Middle East & Africa Sclerotherapy Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Sclerotherapy Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Sclerotherapy Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Sclerotherapy Consumption by Type (2015-2020) (K Pcs)
Table 58. Middle East & Africa Sclerotherapy Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Sclerotherapy Consumption by Application (2015-2020) (K Pcs)
Table 60. Middle East & Africa Sclerotherapy Consumption Market Share by Application (2015-2020)
Table 61. Sclerotherapy Distributors List
Table 62. Sclerotherapy Customer List
Table 63. Global Sclerotherapy Consumption Forecast by Countries (2021-2025) (K Pcs)
Table 64. Global Sclerotherapy Consumption Market Forecast by Regions
Table 65. Global Sclerotherapy Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Sclerotherapy Value Market Share Forecast by Regions
Table 67. Global Sclerotherapy Consumption Forecast by Type (2021-2025) (K Pcs)
Table 68. Global Sclerotherapy Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Sclerotherapy Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Sclerotherapy Value Market Share Forecast by Type (2021-2025)
Table 71. Global Sclerotherapy Consumption Forecast by Application (2021-2025) (K Pcs)
Table 72. Global Sclerotherapy Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Sclerotherapy Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Sclerotherapy Value Market Share Forecast by Application (2021-2025)
Table 75. BTG Product Offered
Table 76. BTG Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 77. BTG Main Business
Table 78. BTG Latest Developments
Table 79. BTG Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 80. MTW ENDOSKOPIE Product Offered
Table 81. MTW ENDOSKOPIE Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 82. MTW ENDOSKOPIE Main Business
Table 83. MTW ENDOSKOPIE Latest Developments
Table 84. MTW ENDOSKOPIE Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 85. Kreussler Product Offered
Table 86. Kreussler Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 87. Kreussler Main Business
Table 88. Kreussler Latest Developments
Table 89. Kreussler Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 90. Troikaa Product Offered
Table 91. Troikaa Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 92. Troikaa Main Business
Table 93. Troikaa Latest Developments
Table 94. Troikaa Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 95. Changan Tianyu group Product Offered
Table 96. Changan Tianyu group Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 97. Changan Tianyu group Main Business
Table 98. Changan Tianyu group Latest Developments
Table 99. Changan Tianyu group Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 100. LGM Pharma Product Offered
Table 101. LGM Pharma Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 102. LGM Pharma Main Business
Table 103. LGM Pharma Latest Developments
Table 104. LGM Pharma Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 105. Angiodynamics Product Offered
Table 106. Angiodynamics Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 107. Angiodynamics Main Business
Table 108. Angiodynamics Latest Developments
Table 109. Angiodynamics Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 110. Bioniche Pharma Group Ltd Product Offered
Table 111. Bioniche Pharma Group Ltd Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 112. Bioniche Pharma Group Ltd Main Business
Table 113. Bioniche Pharma Group Ltd Latest Developments
Table 114. Bioniche Pharma Group Ltd Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 115. ENDO-FLEX Product Offered
Table 116. ENDO-FLEX Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 117. ENDO-FLEX Main Business
Table 118. ENDO-FLEX Latest Developments
Table 119. ENDO-FLEX Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 120. Omega Pharmaceuticals Product Offered
Table 121. Omega Pharmaceuticals Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 122. Omega Pharmaceuticals Main Business
Table 123. Omega Pharmaceuticals Latest Developments
Table 124. Omega Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sclerotherapy Manufacturing Base, Sales Area and Its Competitors
Table 125. Cook Medical Product Offered
Table 126. Cook Medical Sclerotherapy Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 127. Cook Medical Main Business
Table 128. Cook Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Cook Medical Latest Developments
List of Figures
Figure 1. Picture of Sclerotherapy
Figure 2. Sclerotherapy Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Sclerotherapy Consumption Growth Rate 2015-2025 (K Pcs)
Figure 5. Global Sclerotherapy Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Detergents
Figure 7. Product Picture of Osmotic agents
Figure 8. Product Picture of Chemical irritants
Figure 9. Global Sclerotherapy Consumption Market Share by Type (2015-2020)
Figure 10. Global Sclerotherapy Value Market Share by Type (2015-2020)
Figure 11. Sclerotherapy Consumed in Venous disease
Figure 12. Global Sclerotherapy Market: Venous disease (2015-2020) (K Pcs)
Figure 13. Global Sclerotherapy Market: Venous disease (2015-2020) ($ Millions)
Figure 14. Sclerotherapy Consumed in Gastrointestinal bleeding
Figure 15. Global Sclerotherapy Market: Gastrointestinal bleeding (2015-2020) (K Pcs)
Figure 16. Global Sclerotherapy Market: Gastrointestinal bleeding (2015-2020) ($ Millions)
Figure 17. Sclerotherapy Consumed in Bronchopleural fistula
Figure 18. Global Sclerotherapy Market: Bronchopleural fistula (2015-2020) (K Pcs)
Figure 19. Global Sclerotherapy Market: Bronchopleural fistula (2015-2020) ($ Millions)
Figure 20. Sclerotherapy Consumed in Cystic disease
Figure 21. Global Sclerotherapy Market: Cystic disease (2015-2020) (K Pcs)
Figure 22. Global Sclerotherapy Market: Cystic disease (2015-2020) ($ Millions)
Figure 23. Global Sclerotherapy Consumption Market Share by Application (2015-2020)
Figure 24. Global Sclerotherapy Value Market Share by Application (2015-2020)
Figure 25. Global Sclerotherapy Sales Market Share by Company in 2017
Figure 26. Global Sclerotherapy Sales Market Share by Company in 2019
Figure 27. Global Sclerotherapy Revenue Market Share by Company in 2017
Figure 28. Global Sclerotherapy Revenue Market Share by Company in 2019
Figure 29. Global Sclerotherapy Sale Price by Company in 2019
Figure 30. Global Sclerotherapy Consumption Market Share by Regions 2015-2020
Figure 31. Global Sclerotherapy Value Market Share by Regions 2015-2020
Figure 32. Americas Sclerotherapy Consumption 2015-2020 (K Pcs)
Figure 33. Americas Sclerotherapy Value 2015-2020 ($ Millions)
Figure 34. APAC Sclerotherapy Consumption 2015-2020 (K Pcs)
Figure 35. APAC Sclerotherapy Value 2015-2020 ($ Millions)
Figure 36. Europe Sclerotherapy Consumption 2015-2020 (K Pcs)
Figure 37. Europe Sclerotherapy Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Sclerotherapy Consumption 2015-2020 (K Pcs)
Figure 39. Middle East & Africa Sclerotherapy Value 2015-2020 ($ Millions)
Figure 40. Americas Sclerotherapy Consumption Market Share by Countries in 2019
Figure 41. Americas Sclerotherapy Value Market Share by Countries in 2019
Figure 42. Americas Sclerotherapy Consumption Market Share by Type in 2019
Figure 43. Americas Sclerotherapy Consumption Market Share by Application in 2019
Figure 44. United States Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 45. United States Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 47. Canada Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 49. Mexico Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Sclerotherapy Consumption Market Share by Countries in 2019
Figure 51. APAC Sclerotherapy Value Market Share by Regions in 2019
Figure 52. APAC Sclerotherapy Consumption Market Share by Type in 2019
Figure 53. APAC Sclerotherapy Consumption Market Share by Application in 2019
Figure 54. China Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 55. China Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 57. Japan Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 59. Korea Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 61. Southeast Asia Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 62. India Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 63. India Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 65. Australia Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Sclerotherapy Consumption Market Share by Countries in 2019
Figure 67. Europe Sclerotherapy Value Market Share by Countries in 2019
Figure 68. Europe Sclerotherapy Consumption Market Share by Type in 2019
Figure 69. Europe Sclerotherapy Consumption Market Share by Application in 2019
Figure 70. Germany Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 71. Germany Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 72. France Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 73. France Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 74. UK Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 75. UK Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 77. Italy Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 79. Russia Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 80. Spain Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 81. Spain Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 82. Middle East & Africa Sclerotherapy Consumption Market Share by Countries in 2019
Figure 83. Middle East & Africa Sclerotherapy Value Market Share by Countries in 2019
Figure 84. Middle East & Africa Sclerotherapy Consumption Market Share by Type in 2019
Figure 85. Middle East & Africa Sclerotherapy Consumption Market Share by Application in 2019
Figure 86. Egypt Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 87. Egypt Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 88. South Africa Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 89. South Africa Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 90. Israel Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 91. Israel Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 92. Turkey Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 93. Turkey Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 94. GCC Countries Sclerotherapy Consumption Growth 2015-2020 (K Pcs)
Figure 95. GCC Countries Sclerotherapy Value Growth 2015-2020 ($ Millions)
Figure 96. Global Sclerotherapy Consumption Growth Rate Forecast (2021-2025) (K Pcs)
Figure 97. Global Sclerotherapy Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 98. Americas Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 99. Americas Sclerotherapy Value 2021-2025 ($ Millions)
Figure 100. APAC Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 101. APAC Sclerotherapy Value 2021-2025 ($ Millions)
Figure 102. Europe Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 103. Europe Sclerotherapy Value 2021-2025 ($ Millions)
Figure 104. Middle East & Africa Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 105. Middle East & Africa Sclerotherapy Value 2021-2025 ($ Millions)
Figure 106. United States Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 107. United States Sclerotherapy Value 2021-2025 ($ Millions)
Figure 108. Canada Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 109. Canada Sclerotherapy Value 2021-2025 ($ Millions)
Figure 110. Mexico Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 111. Mexico Sclerotherapy Value 2021-2025 ($ Millions)
Figure 112. Brazil Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 113. Brazil Sclerotherapy Value 2021-2025 ($ Millions)
Figure 114. China Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 115. China Sclerotherapy Value 2021-2025 ($ Millions)
Figure 116. Japan Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 117. Japan Sclerotherapy Value 2021-2025 ($ Millions)
Figure 118. Korea Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 119. Korea Sclerotherapy Value 2021-2025 ($ Millions)
Figure 120. Southeast Asia Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 121. Southeast Asia Sclerotherapy Value 2021-2025 ($ Millions)
Figure 122. India Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 123. India Sclerotherapy Value 2021-2025 ($ Millions)
Figure 124. Australia Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 125. Australia Sclerotherapy Value 2021-2025 ($ Millions)
Figure 126. Germany Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 127. Germany Sclerotherapy Value 2021-2025 ($ Millions)
Figure 128. France Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 129. France Sclerotherapy Value 2021-2025 ($ Millions)
Figure 130. UK Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 131. UK Sclerotherapy Value 2021-2025 ($ Millions)
Figure 132. Italy Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 133. Italy Sclerotherapy Value 2021-2025 ($ Millions)
Figure 134. Russia Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 135. Russia Sclerotherapy Value 2021-2025 ($ Millions)
Figure 136. Spain Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 137. Spain Sclerotherapy Value 2021-2025 ($ Millions)
Figure 138. Egypt Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 139. Egypt Sclerotherapy Value 2021-2025 ($ Millions)
Figure 140. South Africa Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 141. South Africa Sclerotherapy Value 2021-2025 ($ Millions)
Figure 142. Israel Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 143. Israel Sclerotherapy Value 2021-2025 ($ Millions)
Figure 144. Turkey Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 145. Turkey Sclerotherapy Value 2021-2025 ($ Millions)
Figure 146. GCC Countries Sclerotherapy Consumption 2021-2025 (K Pcs)
Figure 147. GCC Countries Sclerotherapy Value 2021-2025 ($ Millions)
Figure 148. BTG Sclerotherapy Market Share (2018-2020)
Figure 149. MTW ENDOSKOPIE Sclerotherapy Market Share (2018-2020)
Figure 150. Kreussler Sclerotherapy Market Share (2018-2020)
Figure 151. Troikaa Sclerotherapy Market Share (2018-2020)
Figure 152. Changan Tianyu group Sclerotherapy Market Share (2018-2020)
Figure 153. LGM Pharma Sclerotherapy Market Share (2018-2020)
Figure 154. Angiodynamics Sclerotherapy Market Share (2018-2020)
Figure 155. Bioniche Pharma Group Ltd Sclerotherapy Market Share (2018-2020)
Figure 156. ENDO-FLEX Sclerotherapy Market Share (2018-2020)
Figure 157. Omega Pharmaceuticals Sclerotherapy Market Share (2018-2020)
Figure 158. Cook Medical Sclerotherapy Market Share (2018-2020)


★調査レポート[世界の硬化療法市場予測 2020年-2025年] (コード:LPI20AP3293)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の硬化療法市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆